Preferred Label : Glioblastoma Cancer Vaccine ERC1671;
NCIt definition : A cancer vaccine composed of a combination of autologous glioblastoma (GBM) tumor
cells, allogeneic GBM tumor cells, generated from three different GBM donor cancer
patients, and the lysates of all of these cells, with potential antineoplastic activity.
Upon intradermal administration of GBM cancer vaccine ERC1671, the mixture of the
autologous and allogeneic cells and lysates stimulates the immune system to mount
a cytotoxic T-lymphocyte (CTL) response against GBM-associated antigens, which leads
to the destruction of glioblastoma cells.;
Drug name : Gliovac;
Molecule name : ERC-1671;
NCI Metathesaurus CUI : CL451748;
Origin ID : C107502;
UMLS CUI : C3827065;
Semantic type(s)
- concept_is_in_subset
